A Race between Tumor Immunoescape and Genome Maintenance Selects for Optimum Levels of (epi)genetic Instability
暂无分享,去创建一个
[1] Bert Vogelstein,et al. Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.
[2] S. Pettit,et al. Immune selection in neoplasia: towards a microevolutionary model of cancer development , 2000, British Journal of Cancer.
[3] D. Wodarz,et al. Evolutionary dynamics of mutator phenotypes in cancer: implications for chemotherapy. , 2003, Cancer research.
[4] Adelheid Cerwenka,et al. Natural killer cells, viruses and cancer , 2001, Nature Reviews Immunology.
[5] L. Loeb,et al. A mutator phenotype in cancer. , 2001, Cancer research.
[6] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[7] Manfred Eigen,et al. Error catastrophe and antiviral strategy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Hayday,et al. Regulation of cutaneous malignancy by gammadelta T cells. , 2001, Science.
[9] M. Smyth,et al. Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells , 2004, The Journal of experimental medicine.
[10] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[11] R. D. de Boer,et al. Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus , 2007, Journal of Virology.
[12] Sayuri Yamazaki,et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.
[13] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[14] H. Thomas,et al. Genetic instability in colorectal cancer , 1998, Gut.
[15] A. d’Onofrio. A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences , 2005, 1309.3337.
[16] Michael Loran Dustin,et al. Neural and Immunological Synaptic Relations , 2002, Science.
[17] M. Smyth,et al. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. , 2001, International immunology.
[18] W. Grady,et al. Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.
[19] Rob J. de Boer,et al. Understanding the failure of CD8 T-cell vaccination against simian/human immunodeficiency virus , 2007 .
[20] E. Domingo,et al. Mutagenesis versus Inhibition in the Efficiency of Extinction of Foot-and-Mouth Disease Virus , 2003, Journal of Virology.
[21] L. Loeb,et al. Viral error catastrophe by mutagenic nucleosides. , 2004, Annual review of microbiology.
[22] N. Restifo,et al. Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.
[23] P Hogeweg,et al. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model. , 1985, Journal of immunology.
[24] M. Burnet. Cancer—A Biological Approach , 1957, British medical journal.
[25] A. Nowak,et al. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. , 2003, Cancer research.
[26] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[27] J. Trapani,et al. Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.
[28] C. Janeway. Immunobiology: The Immune System in Health and Disease , 1996 .
[29] Hua Yu,et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.
[30] R. Herberman,et al. Natural cell-mediated immunity. , 1978, Advances in cancer research.
[31] Samuel Litwin,et al. Examining The Theory of Error Catastrophe , 2006, Journal of Virology.
[32] H. Schreiber,et al. Immunodominance and tumor escape. , 2002, Seminars in cancer biology.
[33] M. Nowak,et al. Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy , 1999, Journal of Virology.
[34] R. Schreiber,et al. The three Es of cancer immunoediting. , 2004, Annual review of immunology.
[35] Eric B Haura,et al. Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer , 2005, Nature Clinical Practice Oncology.
[36] M BURNET,et al. Cancer—A Biological Approach* , 1957, British medical journal.
[37] Julia M. Lewis,et al. Regulation of Cutaneous Malignancy by γδ T Cells , 2001, Science.
[38] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[39] Michael Lachmann,et al. Quasispecies Made Simple , 2005, PLoS Comput. Biol..
[40] E. Shakhnovich,et al. Genetic instability and the quasispecies model. , 2006, Journal of theoretical biology.
[41] H. Ljunggren,et al. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. , 1997, Journal of immunology.
[42] I. Svane,et al. Methylcholanthrene‐induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[43] C. Cameron,et al. RNA virus error catastrophe: Direct molecular test by using ribavirin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[45] Federico Garrido,et al. MHC class I antigens, immune surveillance, and tumor immune escape , 2003, Journal of cellular physiology.
[46] H. P. de Vladar,et al. Dynamic response of cancer under the influence of immunological activity and therapy. , 2004, Journal of theoretical biology.
[47] B. Robinson,et al. Immunotherapy and chemotherapy — a practical partnership , 2005, Nature Reviews Cancer.
[48] K. Kinzler,et al. Genetic instability in colorectal cancers , 1997, Nature.
[49] R. Schreiber,et al. A critical function for type I interferons in cancer immunoediting , 2005, Nature Immunology.
[50] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[51] Ricard V Solé,et al. An error catastrophe in cancer? , 2004, Journal of theoretical biology.
[52] Lisette G de Pillis,et al. A validated mathematical model of cell-mediated immune response to tumor growth. , 2007, Cancer research.
[53] M. Zali,et al. Genomic and Epigenetic Instability in Colorectal Cancer , 2013 .
[54] D. Davis,et al. Intrigue at the immune synapse. , 2006, Scientific American.
[55] S. Rosenberg,et al. Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.
[56] Gavin P Dunn,et al. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. , 2006, Advances in immunology.